http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070114197-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90
filingDate 2006-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4e5dcfde81881c4bc9816c425f0c66f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c6211aa1b95cee37463ba574c6d9646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a01b63e9f6435a01f7b41f20ecc0cc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18aff2ee161cddcd1322c8cd3e1691b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c05e8a481781ecfb9fa5d81d299eba29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3daa249d9cac46dbabeeb1f7d0f88624
publicationDate 2007-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20070114197-A
titleOfInvention Derivatives of Aminobutanoic Acid to Inhibit Cititi
abstract The present invention relates to a new class of compounds which act to inhibit carnitine palmitoyl transferase (CPT), pharmaceutical compounds containing at least one novel compound according to the invention, and hyperglycemia such as diabetes mellitus and pathologies associated therewith, It relates to its therapeutic use in the treatment of congestive heart failure and obesity.
priorityDate 2005-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465124402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73038514

Total number of triples: 29.